Health News

Innovative Brands Remain Robust within Kenya's Private Pharmaceutical Market

Author: Australian Business

CAPE TOWN, South Africa, Oct. 2, 2013 /PRNewswire/ -- Recent analysis undertaken by the healthcare unit at Frost & Sullivan Africa has highlighted some of the stronger performing brands in Kenya's pharmaceutical market. Within the anti-infective therapeutic segment analysed, products......

More...

More Articles...

AtheroMed Announces Completion of Patient Enrollment in the EASE Study Evaluating the Phoenix Atherectomy System in Treating PAD
LCA-Vision Reports 4% Increase in Third Quarter 2013 Procedures
Ambit Announces Participation At 12th Annual BIO Investor Forum
PDL BioPharma Provides $60 Million in Financing to LENSAR
US and European Regulators Accept for Review OMS302 Marketing Applications
El NHS de Inglaterra designa a SIRT (radioterapia interna selectiva) como el primer tratamiento disponible a través de la nueva iniciativa "Commissioning through Evaluation"
Expatriates Could be Paying Too Much For International Private Medical Insurance
NHS England torna a SIRT (Radioterapia Seletiva Interna) o primeiro tratamento disponível através da nova iniciativa de comissionamento por avaliação
KLOX Technologies annonce l'approbation au Canada de son traitement novateur contre l'acné simple
Nutranomics Receives Purchase Order from GNC Franchise Owners in the Philippines

Page 1260 of 1908